Aarti Pharmalabs share news and announcements
NSE: AARTIPHARMBSE: 543748Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹828.80.
- Next results date: the board meets on 28 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,443 Cr705th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 3.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.43%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,02,86043.1% delivered
Next board meeting and results date
As the company gave notice to the exchange.Aarti Pharmalabs quarterly results
The board meets on 28 Oct 2026 to consider financial results
Notice filed 9 Oct 2026
Aarti Pharmalabs annual reports, presentations and earnings calls
The company's own documents, latest first.Aarti Pharmalabs financials, year by year
Annual reports4
- Annual report, year to Mar 2026 (opens in a new tab)29 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)29 Aug 2025
- Annual report, year to Mar 2024 (opens in a new tab)15 Jul 2024
- Annual report, year to Mar 2023 (opens in a new tab)22 Aug 2023, a zip file
Investor presentations18
- Investor Presentation made at the 7th Annual General Meeting (opens in a new tab)22 Sep 2026
- Investor Presentation (opens in a new tab)10 Aug 2026
- Investor Presentation (opens in a new tab)26 May 2026
- Investor Presentation (opens in a new tab)10 Feb 2026
- Investor Presentation (opens in a new tab)11 Nov 2025
13 earlier presentations
- Investor Presentation (opens in a new tab)23 Sep 2025
- Investor Presentation (opens in a new tab)13 Aug 2025
- Investor Presentation (opens in a new tab)12 May 2025
- Presentation (opens in a new tab)6 Feb 2025
- Presentation (opens in a new tab)28 Oct 2024
- Investor Presentation (opens in a new tab)7 Aug 2024
- Presentation (opens in a new tab)5 Aug 2024
- Presentation (opens in a new tab)15 May 2024
- Presentation (opens in a new tab)8 Feb 2024
- Presentation (opens in a new tab)8 Nov 2023
- Investor Presentation (opens in a new tab)14 Sep 2023
- Presentation (opens in a new tab)10 Aug 2023
- Investor Presentation (opens in a new tab)26 Jun 2023
Earnings calls26
- Transcript (opens in a new tab)17 Aug 2026
- Link of Recording (opens in a new tab)10 Aug 2026
- Transcript (opens in a new tab)1 Jun 2026
- Link of Recording (opens in a new tab)26 May 2026
- Transcript (opens in a new tab)16 Feb 2026
21 earlier call documents
- Link of Recording (opens in a new tab)10 Feb 2026
- Transcript (opens in a new tab)17 Nov 2025
- Link of Recording (opens in a new tab)11 Nov 2025
- Transcript (opens in a new tab)20 Aug 2025
- Link of Recording (opens in a new tab)13 Aug 2025
- Transcript (opens in a new tab)16 May 2025
- Link of Recording of Investor Meet (opens in a new tab)12 May 2025
- Transcript (opens in a new tab)12 Feb 2025
- Link of Recording (opens in a new tab)7 Feb 2025
- Transcript (opens in a new tab)4 Nov 2024
- Link of Recording (opens in a new tab)28 Oct 2024
- Transcript (opens in a new tab)9 Aug 2024
- Link of Recording (opens in a new tab)6 Aug 2024
- Transcript (opens in a new tab)17 May 2024
- Link of Recording (opens in a new tab)15 May 2024
- Transcript (opens in a new tab)13 Feb 2024
- Link of Recording (opens in a new tab)8 Feb 2024
- Transcript (opens in a new tab)13 Nov 2023
- Link of Recording (opens in a new tab)9 Nov 2023
- Transcript (opens in a new tab)16 Aug 2023
- Link of Recording (opens in a new tab)10 Aug 2023
Aarti Pharmalabs share news and announcements
154 announcements, routine notices left out, newest first. Page 1 of 4.
Oct 2026
22 Oct · Analysts
Sep 2026
23 Sep · Updates
Aug 2026
31 Aug · Management
31 Aug · Management
17 Aug · Corporate action
7 Aug · Management
3 Aug · Analysts
Jul 2026
Jun 2026
May 2026
25 May · Disclosure
20 May · Analysts
20 May · Analysts
11 May · Board meeting
Not held on this date
Apr 2026
Mar 2026
Feb 2026
13 Feb · General Updates
9 Feb · Disclosure
9 Feb · Corporate action
2 Feb · Analysts
Jan 2026
12 Jan · Legal
The exchange asked on 9 Jan 2026
1 Jan · Management
Nov 2025
9 Nov · Management
Oct 2025
13 Oct · Disclosure
Sep 2025
23 Sep · Management
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 1 Sep 2026Board or managers changedup 2.34%+2.8 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+3.3 pts vs Nifty 500) · volume 0.4× usual · delivery −1.5 pts against usual · The announcement (opens in a new tab)
- 10 Aug 2026Resultsup 20.00%+19.9 pts vs Nifty 500market median −0.7% · five sessions +24.1% (+24.6 pts vs Nifty 500) · volume 22.2× usual · delivery −21.9 pts against usual · The announcement (opens in a new tab)
- 10 Feb 2026Dividenddown 3.82%−4.1 pts vs Nifty 500market median 0.0% · five sessions −10.6% (−9.7 pts vs Nifty 500) · volume 2.6× usual · delivery −4.8 pts against usual · The announcement (opens in a new tab)
- 2 Jan 2026Board or managers changeddown 0.28%−1.1 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−0.9 pts vs Nifty 500) · volume 0.6× usual · delivery +13.2 pts against usual · The announcement (opens in a new tab)
- 10 Nov 2025Board or managers changeddown 11.43%−11.8 pts vs Nifty 500market median 0.0% · five sessions −17.5% (−18.9 pts vs Nifty 500) · volume 9.7× usual · delivery −1.4 pts against usual · The announcement (opens in a new tab)
- 10 Nov 2025Resultsdown 11.43%−11.8 pts vs Nifty 500market median −0.7% · five sessions −17.5% (−18.9 pts vs Nifty 500) · volume 9.7× usual · delivery −1.4 pts against usual · The announcement (opens in a new tab)
- 24 Sep 2025Board or managers changeddown 1.61%−1.0 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−2.5 pts vs Nifty 500) · volume 0.4× usual · delivery −12.0 pts against usual · The announcement (opens in a new tab)
- 13 Aug 2025Resultsdown 7.68%−8.3 pts vs Nifty 500market median −0.7% · five sessions −1.8% (−4.4 pts vs Nifty 500) · volume 5.1× usual · delivery −5.3 pts against usual · The announcement (opens in a new tab)
- 17 Jul 2025Credit ratingdown 0.73%−0.5 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−1.7 pts vs Nifty 500) · volume 0.7× usual · delivery −2.0 pts against usual · The announcement (opens in a new tab)
- 12 May 2025Resultsup 4.44%+0.6 pts vs Nifty 500market median −0.7% · five sessions +4.1% (−1.5 pts vs Nifty 500) · volume 4.5× usual · delivery −2.9 pts against usual · The announcement (opens in a new tab)
8 earlier announcements
- 12 May 2025Dividendup 4.44%+0.6 pts vs Nifty 500market median 0.0% · five sessions +4.1% (−1.5 pts vs Nifty 500) · volume 4.5× usual · delivery −2.9 pts against usual · The announcement (opens in a new tab)
- 6 Feb 2025Dividendup 6.86%+7.4 pts vs Nifty 500market median 0.0% · five sessions +16.5% (+20.5 pts vs Nifty 500) · volume 24.0× usual · delivery −26.3 pts against usual · The announcement (opens in a new tab)
- 29 Oct 2024Board or managers changeddown 3.72%−4.4 pts vs Nifty 500market median 0.0% · five sessions +2.9% (+3.4 pts vs Nifty 500) · volume 2.1× usual · delivery −3.8 pts against usual · The announcement (opens in a new tab)
- 6 Aug 2024Resultsdown 3.04%−2.6 pts vs Nifty 500market median −0.7% · five sessions −3.3% (−4.9 pts vs Nifty 500) · volume 0.9× usual · delivery −6.5 pts against usual · The announcement (opens in a new tab)
- 27 Jun 2024Credit ratingdown 2.12%−2.6 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−2.2 pts vs Nifty 500) · volume 0.5× usual · delivery +10.2 pts against usual · The announcement (opens in a new tab)
- 14 May 2024Dividendup 18.84%+18.0 pts vs Nifty 500market median 0.0% · five sessions +18.3% (+15.2 pts vs Nifty 500) · volume 34.0× usual · delivery −25.7 pts against usual · The announcement (opens in a new tab)
- 8 Feb 2024Dividenddown 6.95%−6.3 pts vs Nifty 500market median 0.0% · five sessions −9.2% (−8.3 pts vs Nifty 500) · volume 1.9× usual · delivery −5.7 pts against usual · The announcement (opens in a new tab)
- 6 Mar 2023Credit ratingup 1.75%+1.0 pts vs Nifty 500market median 0.0% · five sessions +0.1% (+2.3 pts vs Nifty 500) · volume 0.7× usual · delivery +10.9 pts against usual · The announcement (opens in a new tab)
Aarti Pharmalabs results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Quarter to Sep 2025 | Standalone | 143.93 | 141.06 | −2.0% | 9 Nov 2025 (opens in a new tab) | 11 Nov 2025 (opens in a new tab) |